MRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
MRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
MRNA科技承诺在癌症治疗上取得长期的突破点。
The medical and pharmaceutical community continues to embrace emerging technologies, beginning with mRNA that rose to fame during the COVID-19 pandemic. The beauty of mRNA technology is that it opens the door to a more personalized and effective treatment as messenger RNA instructs the patient's cells how to combat diseases like cancer.
医疗和药品社区继续拥抱新兴技术，从在COVID-19大流行期间走红的mRNA开始。 mRNA技术的美妙之处在于它打开了更个性化和有效的治疗之门，因为信使RNA指导患者的细胞如何对抗像癌症这样的疾病。
Moderna Inc (NASDAQ:MRNA) and Merck & Co (NYSE:MRK) joined forces to advance cancer treatment with an experimental mRNA vaccine, used in combination with Merck's blockbuster immunotherapy drug Keytruda. With promising mid-stage trial results in the battle against melanoma, the duo is also conducting...
Moderna和Merck & Co强强联手，采用实验性mRNA疫苗结合Merck的畅...
登录免费看全文
登录/注册